Creative Planning
RVMD icon

Creative Planning’s Revolution Medicines RVMD Stock Holding History

Creative Planning’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
64,120
+14,728
+30% +$2.15M 0.01% 755
2026
Q1 		$4.8M Buy
49,392
+5,248
+12% +$530K ﹤0.01% 1229
2025
Q4 		$3.52M Buy
44,144
+5,206
+13% +$341K ﹤0.01% 1257
2025
Q3 		$1.82M Sell
38,938
-26,776
-41% -$1.05M ﹤0.01% 1623
2025
Q2 		$2.42M Buy
65,714
+20,616
+46% +$792K ﹤0.01% 1186
2025
Q1 		$1.59M Buy
45,098
+1,713
+4% +$69.5K ﹤0.01% 1357
2024
Q4 		$1.9M Buy
43,385
+5,517
+15% +$278K ﹤0.01% 1158
2024
Q3 		$1.72M Buy
37,868
+10,839
+40% +$472K ﹤0.01% 1165
2024
Q2 		$1.05M Buy
27,029
+10,667
+65% +$399K ﹤0.01% 1371
2024
Q1 		$527K Buy
+16,362
New +$485K ﹤0.01% 1818

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Creative Planning's RVMD Position: Q2 2026 in Review

Creative Planning increased its Revolution Medicines (RVMD) stake by 30% in Q2 2026, buying an estimated $2.15M and bringing the position to 64,120 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #755.

Creative Planning first reported a position in RVMD in Q1 2024 and has held it in 10 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Creative Planning held 64,120 shares of Revolution Medicines worth $12M as of Q2 2026.
  • Creative Planning bought 14,728 Revolution Medicines shares in Q2 2026, an estimated $2.15M.
  • Revolution Medicines made up 0.01% of Creative Planning's portfolio in Q2 2026, its #755 holding.
  • Creative Planning first reported a position in Revolution Medicines in Q1 2024 and has held it in 10 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.